IBD clinical trials and Foundation research education

Selected Crohn's & Colitis Foundation educational content and Marks are used on IBDPal under license. This page explains how Crohn's and Colitis Foundation clinical trials education helps patients explore research participation with their GI teams. The Foundation does not endorse IBDPal. Education only, not medical advice.

Why trials matter

Clinical trials advance new IBD therapies and monitoring tools.

Participation is voluntary and regulated with informed consent. Symptom patterns tracked over several days are more useful to your clinician than a single snapshot.

Standard care continues alongside many studies. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists.

Finding appropriate trials

Foundation trial finders and academic center websites list enrolling studies.

Inclusion criteria depend on disease type, prior meds, and labs. Write down questions for your gastroenterologist before each visit so limited appointment time is used well.

Your gastroenterologist identifies ethically appropriate options. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends.

Safety and informed consent

Read consent forms carefully. Ask about placebo chances, visit burden, and costs.

Report side effects promptly to study teams. Medication adherence and follow-up labs are as important as diet changes for many IBD patients.

You may withdraw without losing standard care. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment.

Practical participation issues

Travel, time off work, and childcare affect feasibility.

Some studies cover costs; others do not. Tell your team about travel, work stress, sleep changes, and menstrual cycle timing when symptoms shift.

Document trial participation for future clinicians. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway.

After trials end

Extension studies or commercial access may be available.

Maintain follow-up scopes and labs per your GI plan. Bring prior colonoscopy, imaging, and pathology reports when seeing a new IBD specialist.

Share outcomes with your regular IBD team. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit.

Practical tips

Ask your GI about open trials at your center.
Keep consent binders accessible.
Log symptoms consistently during studies.
Verify insurance interaction before enrolling.
Explore Foundation trial finder online.

Common questions

Will I get placebo?

Some trials use placebo; consent explains odds and crossover options.

Are trials only for severe disease?

Studies target varied severity levels with specific criteria.

Can trials replace my GI?

No. Study teams coordinate with your clinicians.

Related resources

Explore the free IBDPal app →

Educational only. Not medical advice. Work with your IBD care team.

Read the full interactive version on ibdpal.org.